Hepatic Surgery for Metastatic Gastrointestinal Neuroendocrine Tumors

Wong R.J. , DeCosse J.J. . Cytoreductive surgery. Surg Gynecol Obstet. 1990; 170: 276–281.

Moertel C.G. . An odyssey in the land of small tumors. J Clin Oncol. 1987; 5: 1502–1522.

Moertel C.G. , Sauer W.G. , Dockerty M.B. . Life history of the carcinoid tumor of the small intestine. Cancer. 1961; 14: 901–912.

Thompson G.B. , van Heerden J.A. , Grant C.S. . Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. 1988; 104: 1011–1017.

Norton J.A. , Doppman J.L. , Jensen R.T. . Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg. 1992; 215: 8–18.

Que F.G. , Nagorney D.M. , Batts K.P. . Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995; 169: 36–43.

Stephen J.L. , Grahame-Smith D.G. . Treatment of the carcinoid syndrome by local removal of hepatic metastases. Proc R Soc Med. 1972; 65: 444–445.

Davis Z. , Moertel C.G. , McIlrath D.C. . The malignant carcinoid syndrome. Surg Gynecol Obstet. 1973; 137: 637–644.

Battersby C. , Egerton W.S. . A carcinoid saga. Aust N Z J Surg. 1974; 44: 32–84.

Fotner J.G. , Kinne D.W. , Kim D.K. . Vascular problems in upper abdominal cancer surgery. Arch Surg. 1974; 109: 148–153.

Gillett D.J. , Smith R.C. . Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of primary lesion. Am J Surg. 1974; 128: 95–99.

Kune G.A. , Goldstein J. . Malignant liver carcinoid: the place of surgery and chemotherapy: review and case presentation. Med J Aust. 1974; 2: 777–780.

Lannon J. . Seventeen cases of hepatectomy. S Afr J Surg. 1974; 12: 227–232.

Longmire WP Jr , Trout HH II , Greenfield J. . Elective hepatic surgery. Ann Surg. 1974; 179: 712–721.

Reiss R. , Antal S.C. . Indications for partial hepatectomy in metastatic disease. Bull Soc Int Chir. 1974; 33: 172–177.

Aronsen K.F. , Torp A. , Waldenstom J.G. . A case of carcinoid syndrome followed for eight years after palliative liver resection. Acta Med Scand. 1976; 199: 327–329.

Foster J.H. , Berman M.M. . Palliative liver resection to relieve symptoms of the malignant carcinoid and other endocrine syndromes. In: Foster J.H. , Berman M.M. , eds. Solid Liver Tumors. Vol. 22. Philadelphia, Pa: WB Saunders Company; 1977: 235–245.

Taylor B. , Langer B. , Falk R.E. . Role of resection in the management of metastases to the liver. Can J Surg. 1983; 26: 215–217.

Thompson H.H. , Tompkins R.K. , Long-mire WP Jr . Major hepatic resection: a 25-year experience. Ann Surg. 1983; 197: 375–388.

Norton J.A. , Sugarbaker P.H. , Dopp-man J.L. . Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986; 203: 352–359.

Stehlin JS Jr , de Ipoli P.D. , Greeff P.J. . Treatment of cancer of the liver. Twenty years’ experience with infusion and resection in 414 patients. Ann Surg. 1988; 208: 23–35.

Akerstrom G. , Makridis C. , Johansson H. . Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol. 1991; 30: 547–553.

Wolf R.F. , Goodnight J.E. , Krag D.E. . Results of resection and proposed guidelines for patient selection in instances of non-colorectal hepatic metastases. Surg Gynecol Obstet. 1991; 173: 454–460.

Dousset B. , Saint-Marc O. , Pitre J. . Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg. 1996; 20: 908–915.

Berney T. , Mentha G. , Roth A.D. . Results of surgical resection of liver metastasis from non-colorectal primaries. Br J Surg. 1998; 85: 1423–1427.

O'Grady J.G. , Polson R.J. , Rolles K. . Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988; 207: 373–379.

Makowka L. , Tzakis A.G. , Mazzaferro V. . Transplantation of the liver for metastatic neuroendocrine tumors of the intestine and pancreas. Surg Gynecol Obstet. 1989; 168: 107–111.

Ringe B. , Wittekind C. , Bechstein W.O. . The role of liver transplantation in hepatobiliary malignancy: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 1989; 209: 88–98.

Alsina A.E. , Bartus S. , Hull D. . Liver transplant for metastatic neuroendocrine tumor. J Clin Gastroenterol. 1990; 12: 533–537.

Gulanikar A.C. , Kotylak G. , Bitter-Suermann H. . Does immunosuppression alter the growth of metastatic liver carcinoid after orthotopic liver transplantation? Transplant Proc. 1991; 23: 2197–2198.

Lobe T.E. , Vera S.R. , Bowman L.C. . Hepaticopancreaticogastroduodenectomy with transplantation for metastatic islet cell carcinoma in childhood. J Pediatr Surg. 1992; 27: 227–229.

Farmer D.G. , Shaked A. , Colonna JO II . Radical resection combined with liver transplantation for foregut tumors. Am Surg. 1993; 59: 806–812.

Schweizer R.T. , Alsina A.E. , Rosson R. . Liver transplantation for metastatic neuroendocrine tumors. Transplant Proc. 1993; 25: 1973.

Bechstein W.O. , Neuhaus P. . Liver transplantation for hepatic metastases of neuroendocrine tumors. Ann N Y Acad Sci. 1994; 733: 507–514.

Frilling A. , Rogiers X. , Knofel W.T. . Liver transplantation for metastatic carcinoid tumors. Digestion. 1994; 55: 104–106.

Alessiani M. , Tzakis A. , Todo S. . Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995; 180: 1–9.

Curtiss S.I. , Mor E. , Schwartz M.E. . A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 1995; 180: 184–187.

Routley D. , Ramage J.K. , McPeake J. . Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg. 1995; 1: 118–121.

Anthuber M. , Jauch K.W. , Briegel J. . Results of liver transplantation for gastroenteropancreatic tumor metastases. World J Surg. 1996; 20: 73–76.

Lang H. , Oldhafer K.J. , Weimann A. . Liver transplantation for metastatic neuroendocrine tumors. Ann Surg. 1997; 225: 347–354.

Le Treut Y.P. , Delpero J.R. , Dousset B. . Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg. 1997; 225: 355–364.

Caplin M.E. , Hodgson H.J. , Dhillon A P. . Multimodality treatment for gastric carcinoid tumor with liver metastasis. Am J Gastroenterol. 1998; 93: 1945–1948.

Hengst K. , Nashan B. , Avenhaus W. . Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation. Zeitschrift fur Gastroenterol. 1998; 36: 239–245.

Savelli G. , Chiti A. , Spinelli A. . Bone lesion in a patient with transplanted liver for a metastatic carcinoid: the role of somatostatin receptor scintigraphy. Tumori. 1998; 84: 82–84.

McEntee G.P. , Nagorney D.M. , Kvols L.K. . Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990; 108: 1091–1096.

Cozzi P.J. , Englund R. , Morris D.L. . Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer. 1995; 76: 501–509.

Bilchik A.J. , Sarantou T. , Foshag L.J. . Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery. 1997; 122: 1040–1048.

McDonald M.L. , Nagorney D.M. , Connolly H.M. . Carcinoid heart disease and carcinoid syndrome: successful surgical treatment. Ann Thorac Surg. 1999; 67: 537–539.

Lehnert T. . Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation. 1998; 66: 1307–1312.

Kelsen D.G. , Cheng E. , Kemeny . Streptozotocin and Adriamycin in the treatment of APUD tumors. Proc Annu Meet Am Assoc Cancer Res. 1982; 23: 433.

Oberg K. . Advances in chemotherapy and biotherapy of endocrine tumors. Curr Opin Oncol. 1998; 10: 58–65.

Moertel C.G. , Lefkopoulo M. , Lipsitz S. . Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med. 1992; 326: 519–523.

Kvols L.K. . Therapy of the malignant carcinoid syndrome. Endocrinol Metab Clin North Am. 1989; 18: 557–568.

Moertel C.G. , Johnson C.M. , McKusick M.A. . The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994; 120: 302–309.

Moertel C.G. , Kvols L.K. , O'Connell M.J. . Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991; 68: 227–232.

Eriksson B. , Oberg K. . Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol. 1999; 10: S31–538.

Oberg K. . Interferon-alpha versus somatostatin or the combination of both in gastroenteropancreatic tumours. Digestion. 1996; 57: 81–83.